Korea Investment Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127M Sell
1,003,135
-129,380
-11% -$17M 0.24% 72
2026
Q1
$158M Sell
1,132,515
-225,908
-17% -$31.6M 0.33% 51
2025
Q4
$167M Buy
1,358,423
+7,105
+0.5% +$863K 0.33% 48
2025
Q3
$150M Buy
1,351,318
+209,246
+18% +$23.8M 0.31% 50
2025
Q2
$127M Sell
1,142,072
-98,262
-8% -$10.5M 0.28% 65
2025
Q1
$139M Buy
1,240,334
+102,232
+9% +$10.5M 0.34% 50
2024
Q4
$105M Sell
1,138,102
-82,725
-7% -$7.45M 0.25% 78
2024
Q3
$102M Buy
1,220,827
+266,410
+28% +$20.3M 0.24% 85
2024
Q2
$65.5M Sell
954,417
-50,938
-5% -$3.4M 0.17% 116
2024
Q1
$73.6M Sell
1,005,355
-58,159
-5% -$4.47M 0.19% 118
2023
Q4
$86.2M Sell
1,063,514
-28,581
-3% -$2.22M 0.23% 97
2023
Q3
$81.8M Sell
1,092,095
-64,984
-6% -$5M 0.24% 96
2023
Q2
$89.2M Sell
1,157,079
-299,840
-21% -$23.9M 0.25% 91
2023
Q1
$121M Buy
1,456,919
+225,251
+18% +$18.7M 0.35% 65
2022
Q4
$106M Sell
1,231,668
-379,581
-24% -$30.1M 0.33% 75
2022
Q3
$99.4M Buy
1,611,249
+455,962
+39% +$28.8M 0.31% 72
2022
Q2
$71.4M Sell
1,155,287
-5,691
-0.5% -$352K 0.22% 109
2022
Q1
$69M Buy
1,160,978
+550,852
+90% +$35.2M 0.17% 144
2021
Q4
$44.3M Buy
610,126
+38,424
+7% +$2.65M 0.12% 195
2021
Q3
$39.9M Sell
571,702
-143,452
-20% -$10.1M 0.12% 188
2021
Q2
$49.2M Buy
715,154
+39,029
+6% +$2.61M 0.14% 177
2021
Q1
$43.7M Sell
676,125
-149,573
-18% -$9.64M 0.14% 174
2020
Q4
$48.1M Sell
825,698
-16,226
-2% -$979K 0.14% 174
2020
Q3
$53.2M Sell
841,924
-26,400
-3% -$1.83M 0.19% 150
2020
Q2
$66.8M Buy
868,324
+23,600
+3% +$1.81M 0.25% 103
2020
Q1
$63.2M Sell
844,724
-31,801
-4% -$2.2M 0.28% 93
2019
Q4
$57M Buy
876,525
+86,900
+11% +$5.66M 0.21% 132
2019
Q3
$50M Buy
789,625
+39,400
+5% +$2.58M 0.21% 124
2019
Q2
$50.7M Sell
750,225
-105,200
-12% -$6.92M 0.22% 124
2019
Q1
$55.6M Buy
855,425
+96,658
+13% +$6.42M 0.25% 100
2018
Q4
$47.5M Buy
758,767
+6,900
+0.9% +$482K 0.26% 92
2018
Q3
$58.1M Sell
751,867
-194,788
-21% -$14.7M 0.27% 92
2018
Q2
$67.1M Sell
946,655
-167,400
-15% -$11.8M 0.31% 79
2018
Q1
$84M Sell
1,114,055
-176,399
-14% -$14M 0.39% 63
2017
Q4
$92.4M Buy
1,290,454
+135,070
+12% +$10.3M 0.42% 56
2017
Q3
$93.6M Buy
1,155,384
+84,900
+8% +$6.49M 0.43% 44
2017
Q2
$75.8M Buy
1,070,484
+2,798
+0.3% +$186K 0.35% 60
2017
Q1
$72.5M Sell
1,067,686
-525,240
-33% -$36.9M 0.36% 55
2016
Q4
$114M Sell
1,592,926
-53,343
-3% -$3.96M 0.55% 32
2016
Q3
$130M Buy
1,646,269
+76,745
+5% +$6.23M 0.69% 24
2016
Q2
$131M Buy
1,569,524
+218,600
+16% +$19.4M 0.78% 23
2016
Q1
$124M Buy
1,350,924
+134,600
+11% +$12.1M 0.91% 17
2015
Q4
$123M Buy
1,216,324
+101,600
+9% +$10.6M 0.86% 15
2015
Q3
$109M Buy
1,114,724
+234,824
+27% +$26.1M 0.87% 14
2015
Q2
$103M Sell
879,900
-100,900
-10% -$11M 0.88% 13
2015
Q1
$96.2M Sell
980,800
-9,100
-0.9% -$924K 0.75% 16
2014
Q4
$93.3M Sell
989,900
-35,400
-3% -$3.66M 0.77% 16
2014
Q3
$109M Sell
1,025,300
-53,400
-5% -$5.23M 0.89% 14
2014
Q2
$89.4M Buy
1,078,700
+7,100
+0.7% +$553K 0.74% 21
2014
Q1
$75.9M Buy
1,071,600
+110,870
+12% +$8.7M 0.67% 22
2013
Q4
$72.2M Buy
960,730
+243,800
+34% +$17M 0.68% 26
2013
Q3
$45.1M Sell
716,930
-57,670
-7% -$3.45M 0.48% 49
2013
Q2
$39.7M Buy
+774,600
New +$40.4M 0.48% 44

Other funds holding GILD

Korea Investment Corp's GILD Position: Q2 2026 in Review

Korea Investment Corp reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $17M and leaving 1,003,135 shares worth $127M. The position accounts for 0.24% of the portfolio, ranked #72.

Korea Investment Corp first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $167M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Korea Investment Corp held 1,003,135 shares of Gilead Sciences worth $127M as of Q2 2026.
  • Korea Investment Corp sold 129,380 Gilead Sciences shares in Q2 2026, an estimated $17M.
  • Gilead Sciences made up 0.24% of Korea Investment Corp's portfolio in Q2 2026, its #72 holding.
  • Korea Investment Corp first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Korea Investment Corp's Gilead Sciences position peaked at $167M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.